Previous Close | 24.72 |
Open | 24.68 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 24.65 - 25.83 |
52 Week Range | 4.22 - 26.43 |
Volume | |
Avg. Volume | 693,237 |
Market Cap | 1.774B |
Beta (5Y Monthly) | 2.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of 0% and 9.11%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this article, we are going to take a look at where Nurix Therapeutics, Inc. (NASDAQ:NRIX) stands against the other small-cap healthcare stocks. Healthcare Sector: A Defensive Investment with Growth Potential in 2024 In difficult economic times, healthcare equities are sometimes […]